1. Home
  2. MHO vs GPCR Comparison

MHO vs GPCR Comparison

Compare MHO & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MHO

M/I Homes Inc.

N/A

Current Price

$136.21

Market Cap

3.4B

ML Signal

N/A

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

N/A

Current Price

$21.89

Market Cap

3.8B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MHO
GPCR
Founded
1976
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.8B
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
MHO
GPCR
Price
$136.21
$21.89
Analyst Decision
Buy
Strong Buy
Analyst Count
4
16
Target Price
★ $156.67
$107.29
AVG Volume (30 Days)
347.2K
★ 1.0M
Earning Date
10-21-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 8.14
N/A
Revenue
★ $4,417,781,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.77
N/A
P/E Ratio
$16.21
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$113.40
$18.70
52 Week High
$163.66
$94.90

Technical Indicators

Market Signals
Indicator
MHO
GPCR
Relative Strength Index (RSI) 57.04 38.88
Support Level $117.51 $20.73
Resistance Level $137.11 $22.36
Average True Range (ATR) 5.39 1.31
MACD 1.84 0.59
Stochastic Oscillator 83.53 65.58

Price Performance

Historical Comparison
MHO
GPCR

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprises a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: